pancreas_001:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma (PDAC)
  biomarker_profile: "KRAS G12D mutation detected. BRCA1/2 germline testing negative. TP53 p.R175H mutation identified. MSI-stable, TMB low (2.3 mut/Mb)."

pancreas_002:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "BRCA2 pathogenic variant c.5946delT (germline). KRAS wild-type. HRD positive."

pancreas_003:
  morphology: NEUROENDOCRINE
  descriptive_name: Pancreatic neuroendocrine tumor (pNET)
  biomarker_profile: "No targetable alterations identified."

pancreas_004:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12C mutation. MSI-H detected. TMB elevated at 18 mutations/megabase."

pancreas_005:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic cancer
  biomarker_profile: "Comprehensive genomic profiling revealed KRAS p.G12V, TP53 p.Y220C, and PALB2 germline mutation c.3113G>A."

pancreas_006:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal adenocarcinoma of pancreas
  biomarker_profile: "KRAS G12R detected by ddPCR. BRCA testing pending."

pancreas_007:
  morphology: NEUROENDOCRINE
  descriptive_name: Well-differentiated pancreatic NET, Grade 2
  biomarker_profile: "Ki-67 proliferation index: 8%"

pancreas_008:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "No actionable mutations detected. KRAS/BRCA1/BRCA2/PALB2 all wild-type. MSS, TMB-L."

pancreas_009:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12D+, TP53 R248W+, BRCA1/2 neg"

pancreas_010:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic pancreatic adenocarcinoma
  biomarker_profile: "NGS: KRAS c.35G>A (p.G12D), TP53 loss-of-function mutation. Germline BRCA2 p.K3326X (VUS). MMR proficient."

pancreas_011:
  morphology: NEUROENDOCRINE
  descriptive_name: Pancreatic neuroendocrine carcinoma
  biomarker_profile: "High-grade NEC with Ki-67 >20%. No additional molecular testing performed."

pancreas_012:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma
  biomarker_profile: "BRCA1 germline pathogenic variant identified (c.68_69delAG). KRAS G12V somatic mutation present."

pancreas_013:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "MSI-high tumor. TMB 45 mut/Mb. KRAS WT."

pancreas_014:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS p.Q61H"

pancreas_015:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic cancer, ductal type
  biomarker_profile: "Liquid biopsy detected KRAS G12D at 2.3% VAF. Tissue confirmation pending."

pancreas_016:
  morphology: NEUROENDOCRINE
  descriptive_name: Functioning insulinoma
  biomarker_profile: "Molecular profiling not indicated for this well-differentiated NET."

pancreas_017:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "PALB2 truncating mutation (germline). KRAS G12V (somatic). TP53 p.R273H. MSS."

pancreas_018:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal adenoCA
  biomarker_profile: "Standard panel negative including KRAS, BRAF, BRCA1/2, PALB2"

pancreas_019:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12D detected. Homologous recombination deficiency (HRD) score: negative. TMB: 3.2 mutations/Mb."

pancreas_020:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "FoundationOne CDx: KRAS p.G12C, TP53 p.H179R, CDKN2A/B deletion. No germline alterations."

pancreas_021:
  morphology: NEUROENDOCRINE
  descriptive_name: pNET, non-functional
  biomarker_profile: "Grade 1 tumor, Ki-67 <3%"

pancreas_022:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic PDAC
  biomarker_profile: "ctDNA analysis: KRAS G12V mutation detected at 12% allele frequency."

pancreas_023:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma
  biomarker_profile: "BRCA2 c.9097dupA (pathogenic, germline). Eligible for PARP inhibitor therapy."

pancreas_024:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic carcinoma
  biomarker_profile: "Molecular testing: All markers negative."

pancreas_025:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS codon 12 mutation present (specific variant not determined). TP53 mutant. BRCA1/2 wild-type. MSI-stable, TMB-low."

pancreas_026:
  morphology: NEUROENDOCRINE
  descriptive_name: Pancreatic neuroendocrine tumor
  biomarker_profile: "Well-differentiated, Grade 2, Ki-67 index 5%"

pancreas_027:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "Comprehensive profiling revealed no targetable alterations. KRAS/TP53/BRCA1/BRCA2/PALB2 all negative."

pancreas_028:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12R, TP53 R282W"

pancreas_029:
  morphology: ADENOCARCINOMA
  descriptive_name: Adenocarcinoma of pancreatic head
  biomarker_profile: "NGS panel: KRAS p.G12D (VAF 23%), TP53 p.Y163C (VAF 18%), SMAD4 loss. MMR-proficient, TMB 4 mut/Mb."

pancreas_030:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic cancer
  biomarker_profile: "Germline testing identified BRCA1 c.5266dupC pathogenic variant. Somatic KRAS G12V also present."

pancreas_031:
  morphology: NEUROENDOCRINE
  descriptive_name: High-grade pancreatic NEC
  biomarker_profile: "Poorly differentiated, Ki-67 >50%"

pancreas_032:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "MSI-high. TMB 28 mut/Mb. Immunotherapy candidate."

pancreas_033:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma
  biomarker_profile: "KRAS G12A mutation. TP53 null mutation. PALB2 VUS identified on germline testing."

pancreas_034:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "Wild-type for all tested markers"

pancreas_035:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC, tail of pancreas
  biomarker_profile: "Liquid biopsy: KRAS G12D detected. Tissue biopsy: KRAS G12D confirmed, TP53 p.R175H, CDKN2A deletion."

pancreas_036:
  morphology: NEUROENDOCRINE
  descriptive_name: Gastrinoma (pancreatic primary)
  biomarker_profile: "Functional NET, no molecular profiling performed"

pancreas_037:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "BRCA2 p.S1982Rfs*22 (pathogenic, germline). KRAS p.G12C (somatic). HRD-positive."

pancreas_038:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS+"

pancreas_039:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic carcinoma, ductal
  biomarker_profile: "Tempus xT: KRAS G12D (35% VAF), TP53 R248Q (28% VAF), SMAD4 deletion. MSS, TMB-L (2.5 mut/Mb)."

pancreas_040:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic pancreatic adenocarcinoma
  biomarker_profile: "PALB2 germline mutation c.1592delT detected. Patient referred for genetic counseling."

pancreas_041:
  morphology: NEUROENDOCRINE
  descriptive_name: Well-differentiated pNET
  biomarker_profile: "Grade 1, mitotic count <2/10 HPF, Ki-67 1%"

pancreas_042:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma
  biomarker_profile: "No mutations detected in KRAS (including G12C), BRCA1, BRCA2, or PALB2. Microsatellite stable."

pancreas_043:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12V+, TP53 mutant, BRCA2 germline+"

pancreas_044:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "Guardant360: KRAS p.G12D detected in circulating tumor DNA at 8.2% allele fraction."

pancreas_045:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal adenocarcinoma
  biomarker_profile: "MSI-H identified. MLH1/PMS2 loss by IHC. TMB elevated."

pancreas_046:
  morphology: NEUROENDOCRINE
  descriptive_name: Pancreatic NET, Grade 3
  biomarker_profile: "Well-differentiated, Ki-67 25%"

pancreas_047:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "Molecular profiling shows KRAS G12D mutation and TP53 p.R273C mutation."

pancreas_048:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic cancer
  biomarker_profile: "BRCA1 germline pathogenic variant c.3756_3759delGTCT"

pancreas_049:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma
  biomarker_profile: "All biomarkers tested negative. MSS. TMB-low."

pancreas_050:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12R (VAF 41%), TP53 Y220C (VAF 38%), CDKN2A homozygous deletion, SMAD4 R361C"

pancreas_051:
  morphology: NEUROENDOCRINE
  descriptive_name: Non-functioning pNET
  biomarker_profile: "Grade 2, Ki-67 12%, well-differentiated"

pancreas_052:
  morphology: ADENOCARCINOMA
  descriptive_name: Adenocarcinoma of pancreas
  biomarker_profile: "KRAS wild-type (rare). Extended testing revealed GNAS R201H mutation."

pancreas_053:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "Germline panel: PALB2 c.2167_2168delAT (pathogenic). Somatic: KRAS G12V."

pancreas_054:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "NGS negative"

pancreas_055:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal carcinoma
  biomarker_profile: "KRAS p.G12D detected by PCR. BRCA1/2 analysis: no pathogenic variants. TP53 p.R175H identified."

pancreas_056:
  morphology: NEUROENDOCRINE
  descriptive_name: VIPoma
  biomarker_profile: "Functional pNET, clinical diagnosis"

pancreas_057:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic PDAC
  biomarker_profile: "TMB-high (22 mut/Mb). MSI-high. MLH1 methylation detected."

pancreas_058:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "BRCA2 somatic mutation p.E1493* detected. Germline BRCA2 negative."

pancreas_059:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12C mutation identified. Potential candidate for KRAS G12C inhibitor."

pancreas_060:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic cancer, ductal
  biomarker_profile: "Comprehensive genomic profiling: No alterations detected in 324-gene panel."

pancreas_061:
  morphology: NEUROENDOCRINE
  descriptive_name: Pancreatic neuroendocrine tumor
  biomarker_profile: "Grade 1, Ki-67 <2%, no further testing"

pancreas_062:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS p.Q61H, TP53 splice site mutation"

pancreas_063:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "Hereditary cancer panel positive for BRCA1 p.Q1777* (pathogenic). KRAS G12D present."

pancreas_064:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal adenocarcinoma of pancreas
  biomarker_profile: "MSI testing: Stable. TMB: Low (1.8 mutations/Mb). KRAS: G12V positive."

pancreas_065:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC, body of pancreas
  biomarker_profile: "Cell-free DNA analysis: KRAS G12D (4.1% MAF), TP53 R282W (3.8% MAF)"

pancreas_066:
  morphology: NEUROENDOCRINE
  descriptive_name: Poorly differentiated pancreatic NEC
  biomarker_profile: "High-grade, Ki-67 >80%, small cell morphology"

pancreas_067:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "PALB2 germline VUS c.2014G>C. KRAS G12D somatic. Clinical significance uncertain."

pancreas_068:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "Wild-type"

pancreas_069:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma
  biomarker_profile: "Caris MI: KRAS G12V, TP53 G245S, ARID1A Q669*, MSI-stable, TMB-low, HRD-negative"

pancreas_070:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic pancreatic cancer
  biomarker_profile: "BRCA2 c.5946delT (germline pathogenic). Platinum-sensitive disease."

pancreas_071:
  morphology: NEUROENDOCRINE
  descriptive_name: Well-differentiated NET
  biomarker_profile: "Grade 2, mitotic rate 3/10 HPF"

pancreas_072:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12A detected. Rest of panel negative."

pancreas_073:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "Microsatellite instability-high. IHC shows loss of MSH2 and MSH6. TMB 18.2 mut/Mb."

pancreas_074:
  morphology: ADENOCARCINOMA
  descriptive_name: Adenocarcinoma, pancreatic origin
  biomarker_profile: "Standard biomarker panel all negative"

pancreas_075:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12D+, TP53+, CDKN2A del"

pancreas_076:
  morphology: NEUROENDOCRINE
  descriptive_name: Somatostatinoma
  biomarker_profile: "Rare functional pNET"

pancreas_077:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic ductal adenocarcinoma
  biomarker_profile: "BRCA1 germline mutation c.1961delA detected. HRD score positive. KRAS G12R somatic."

pancreas_078:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic cancer
  biomarker_profile: "KRAS mutation absent. Further testing for rare variants ongoing."

pancreas_079:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "Liquid biopsy negative. Tissue insufficient for molecular testing."

pancreas_080:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal pancreatic carcinoma
  biomarker_profile: "OncomineDx: KRAS p.G12D (23.4% frequency), TP53 p.C238Y (19.2% frequency), SMAD4 p.D351H"

pancreas_081:
  morphology: NEUROENDOCRINE
  descriptive_name: pNET, well-differentiated
  biomarker_profile: "Grade 1, Ki-67 index <1%"

pancreas_082:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "PALB2 p.Y551* germline pathogenic variant. Referred to genetics. KRAS G12V somatic."

pancreas_083:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "TMB-H (15 mut/Mb), MSI-H"

pancreas_084:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic pancreatic ductal adenocarcinoma
  biomarker_profile: "KRAS p.G12C identified. Clinical trial screening for KRAS G12C inhibitor initiated."

pancreas_085:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic carcinoma
  biomarker_profile: "No targetable mutations identified on 50-gene panel."

pancreas_086:
  morphology: NEUROENDOCRINE
  descriptive_name: Intermediate-grade pNET
  biomarker_profile: "Grade 2, Ki-67 15%, well-differentiated"

pancreas_087:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12V (somatic), BRCA2 K3326X (germline VUS)"

pancreas_088:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma, unresectable
  biomarker_profile: "FoundationOne Liquid CDx: KRAS G12D detected at 5.8% VAF in ctDNA."

pancreas_089:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal adenocarcinoma
  biomarker_profile: "All markers WT including KRAS (confirmed by repeat testing)"

pancreas_090:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS p.G12D, TP53 p.R273H, CDKN2A/B co-deletion, SMAD4 loss, MSS, TMB-L"

pancreas_091:
  morphology: NEUROENDOCRINE
  descriptive_name: Glucagonoma
  biomarker_profile: "Functional tumor with glucagonoma syndrome"

pancreas_092:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic cancer
  biomarker_profile: "Germline testing: BRCA2 c.8167G>C pathogenic. Eligible for olaparib maintenance."

pancreas_093:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC, locally advanced
  biomarker_profile: "KRAS G12D mutation. TP53 mutation. BRCA/PALB2 negative. MSI-stable."

pancreas_094:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "Insufficient tissue for molecular analysis"

pancreas_095:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS WT, TP53 WT, unusual molecular profile"

pancreas_096:
  morphology: NEUROENDOCRINE
  descriptive_name: Large cell pancreatic NEC
  biomarker_profile: "Poorly differentiated, Ki-67 60%"

pancreas_097:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal adenocarcinoma of pancreatic tail
  biomarker_profile: "Next-generation sequencing: KRAS p.G12R (VAF 18%), TP53 p.V157F (VAF 22%), BRCA1/2 germline negative"

pancreas_098:
  morphology: ADENOCARCINOMA
  descriptive_name: Pancreatic adenocarcinoma
  biomarker_profile: "MSI-high tumor with MLH1 promoter hypermethylation. TMB 32 mutations/Mb. KRAS wild-type."

pancreas_099:
  morphology: ADENOCARCINOMA
  descriptive_name: PDAC
  biomarker_profile: "KRAS G12D+"

pancreas_100:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic pancreatic ductal adenocarcinoma
  biomarker_profile: "Comprehensive panel: KRAS p.G12V (28% VAF), TP53 p.R248W (31% VAF), CDKN2A deletion, PALB2 germline c.2257C>T pathogenic variant identified."